Tag results:

lymphoid cells

CAMTA1–PPP3CA–NFATc4 Multi-Protein Complex Mediates the Resistance of Colorectal Cancer to Oxaliplatin

[Cell Death Discovery] In functional in vitro experiments, researchers observed that calmodulin-binding transcription activator 1 (Camta1) overexpression significantly decreased the proliferation and invasion capacity of SW620 and SW480 cells.

Single-Cell Multiomics Reveals Persistence of HIV-1 in Expanded Cytotoxic T Cell Clones

[Immunity] Researchers used single-cell ECCITE-seq, which captures surface protein expression, cellular transcriptome, HIV-1 RNA, and TCR sequences within the same single cell to track clonal expansion dynamics in longitudinally archived samples from six HIV-1-infected individuals and two uninfected individuals.

Listeria Delivers Tetanus Toxoid Protein to Pancreatic Tumors and Induces Cancer Cell Death in Mice

[Science Translational Medicine] The authors presented a microbial-based immunotherapeutic treatment for selective delivery of an immunogenic tetanus toxoid protein into pancreatic ductal adenocarcinom tumor cells by attenuated Listeria monocytogenes.

CRISPR Activation Screen Identifies BCL-2 Proteins and B3GNT2 as Drivers of Cancer Resistance to T Cell-Mediated Cytotoxicity

[Nature Communications] By investigating the resistance mechanisms, scientists found that MCL1 and JUNB modulated the mitochondrial apoptosis pathway. JUNB encoded a transcription factor that downregulates FasL and TRAIL receptors, upregulated the MCL1 relative BCL2A1, and activated the NF-κB pathway.

Immune Responses in the Parkinsons’s Disease Brain

[Neurobiology of Disease] Current evidence points towards infiltrating monocytes as also playing a role in neuron death. Further characterization of the successive molecular changes in both the resident and peripheral immune cells invading the Parkinson's disease brain will provide targets for disease modification.

Targeting Toll-Like Receptors on T Cells as a Therapeutic Strategy against Tumors

[International Immunology] The authors summarize the advances in our understanding of the ability of different types of TLRs and their downstream signaling pathways to activate anti-tumor immunity in T cells.

Popular